Skip to main content
GENERAL PSYCHIATRY

Thrombolytic Therapy in Cocaine Users with Ischemic Stroke: A Review of Current Practice

Psychopharmacology Bulletin 49(1): 70-79, 2019/02/15; https://doi.org/10.64719/pb.4583

Abstract

Alteplase is the main pharmacological treatment available for intravenous thrombolysis in patients with acute ischemic stroke. Endovascular treatment alone or add-on to intravenous thrombolysis is a valid approach in acute ischemic stroke with cerebral large vessel disease. The most common serious adverse reaction related to alteplase is the development of spontaneous intracerebral hemorrhage and the presence of cerebral small vessel disease may increase this risk, particularly in cocaine users, even if only few data have been published on this topic. Here we reviewed in cocaine users with acute ischemic stroke the efficacy and safety of thrombolytic therapy.

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Antonio Siniscalchi, Giovambattista De Sarro, Roberta Pacifici, Ermanno Pisani, Sandro Sanguigni, Luca Gallelli. Thrombolytic Therapy in Cocaine Users with Ischemic Stroke: A Review of Current Practice. Psychopharmacology Bulletin. 2019/02/15; 49(1):70-79. https://doi.org/10.64719/pb.4583